Henit Yanai

Levels of Drug and Antidrug Antibodies Are Associated With Outcome of Interventions After Loss of Response to Infliximab or Adalimumab

Henit Yanai, Lev Lichtenstein, Amit Assa et al. · Clinical Gastroenterology and Hepatology · 2014 · 306 citations

Anti-inflammatory, Autoimmune Disease, Immunology +6

Patient Factors That Increase Infliximab Clearance and Shorten Half-life in Inflammatory Bowel Disease

Iris Dotan, Yulia Ron, Henit Yanai et al. · Inflammatory Bowel Diseases · 2014 · 277 citations · Full text

ECCO Guidelines on Therapeutics in Crohn’s Disease: Medical Treatment

Hannah Gordon, Silvia Minozzi, Uri Kopylov et al. · Journal of Crohn s and Colitis · 2024 · 240 citations · Full text

Dietary Therapy With the Crohn’s Disease Exclusion Diet is a Successful Strategy for Induction of Remission in Children and Adults Failing Biological Therapy

Rotem Sigall Boneh, Chen Sarbagili‐Shabat, Henit Yanai et al. · Journal of Crohn s and Colitis · 2017 · 190 citations · Full text

ECCO Guidelines on Therapeutics in Crohn’s Disease: Surgical Treatment

Michel Adamina, Silvia Minozzi, Janindra Warusavitarne et al. · Journal of Crohn s and Colitis · 2024 · 114 citations · Full text

Gastroenterology, Visceral Surgery, Surgery +8